Related Experiment Video
Updated: Mar 18, 2026

Monitoring the Effect of Osmotic Stress on Secretory Vesicles and Exocytosis
Published on: February 19, 2018
Effect of heart failure on catecholamine granule morphology and storage in chromaffin cells
Sushil K Mahata1, Hong Zheng2, Sumana Mahata3
1VA San Diego Healthcare System Metabolic Physiology & Ultrastructural Biology Lab.Department of Medicine, University of California at San Diego, La Jolla, CA, USA.
Insights
Chronic heart failure (HF) activates adrenal glands, increasing catecholamines. This study reveals structural changes in adrenal chromaffin cells, enhancing catecholamine synthesis and release in HF rats.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Cell Biology
Background:
- Sympathoexcitation is a hallmark of chronic heart failure (HF).
- Adrenal gland activation and elevated circulating catecholamines contribute to HF pathophysiology.
- The specific in vivo structural and metabolic adaptations of adrenomedullary chromaffin cells in HF remain largely uncharacterized.
Purpose of the Study:
- To investigate the in vivo structural and metabolic changes in adrenal chromaffin cells in a rat model of chronic heart failure.
- To elucidate the relationship between sympathoexcitation, adrenal gland overactivation, and catecholamine production in HF.
Main Methods:
- Chronic heart failure (HF) was induced in male Sprague-Dawley rats via left coronary artery ligation.
- Cardiac function was assessed using ventricular hemodynamics five weeks post-surgery.
- Adrenal glands were examined for structural alterations, catecholamine levels, and cellular organelle morphology in HF versus sham-operated rats.
Main Results:
- HF rats exhibited increased adrenal weight and elevated levels of norepinephrine, epinephrine, and dopamine compared to controls.
- Ultrastructural analysis revealed increased synaptic vesicles, endoplasmic reticulum, Golgi apparatus, and mitochondria with dilated cristae and glycogen in chromaffin cells of HF rats.
- These morphological changes suggest enhanced trans-synaptic activation and increased capacity for catecholamine synthesis and release.
Conclusions:
- Chronic heart failure induces significant structural and metabolic adaptations in adrenal chromaffin cells to support heightened catecholamine production.
- These cellular adaptations provide a mechanistic link between HF, adrenal overactivation, and elevated plasma catecholamines.
- The findings offer novel insights into the neurohumoral mechanisms driving cardiovascular dysfunction in chronic heart failure.
Abstract:
One of the key mechanisms involved in sympathoexcitation in chronic heart failure (HF) is the activation of the adrenal glands. Impact of the elevated catecholamines on the hemodynamic parameters has been previously demonstrated. However, studies linking the structural effects of such overactivation with secretory performance and cell metabolism in the adrenomedullary chromaffin cells in vivo have not been previously reported. In this study, HF was induced in male Sprague-Dawley rats by ligation of the left coronary artery. Five weeks after surgery, cardiac function was assessed by ventricular hemodynamics. HF rats showed increased adrenal weight and adrenal catecholamine levels (norepinephrine, epinephrine and dopamine) compared with sham-operated rats. Rats with HF demonstrated increased small synaptic and dense core vesicle in splanchnic-adrenal synapses indicating trans-synaptic activation of catecholamine biosynthetic enzymes, increased endoplasmic reticulum and Golgi lumen width to meet the demand of increased catecholamine synthesis and release, and more mitochondria with dilated cristae and glycogen to accommodate for the increased energy demand for the increased biogenesis and exocytosis of catecholamines from the adrenal medulla. These findings suggest that increased trans-synaptic activation of the chromaffin cells within the adrenal medulla may lead to increased catecholamines in the circulation which in turn contributes to the enhanced neurohumoral drive, providing a unique mechanistic insight for enhanced catecholamine levels in plasma commonly observed in chronic HF condition.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which...
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inotropic Agents

